Cellcept is a medication normally used in heart or liver transplant patients to prevent organ rejection. Cellcept lowers immune system response.
However, Cellcept has also recently been shown to be effective in slowing down the progression of Multiple Sclerosis. Several clinical trials are in progress combining Cellcept with the subcutaneous interferon treatment Avonex. Results are promising, and could potentially be a viable treatment for patients with Primary-Progressive MS (PPMS). Cellcept is also an off-label treatment for lupus. It is an effective immunosuppresent.
Chat with our AI personalities